To explore the underlying mechanism by which TRIM26 inhibits osteosarcoma progression, we performed RNA-seq analysis and found that TRIM26 overexpression-induced-differentially expressed genes were particularly enriched in mitogen-activated protein kinase (MAPK) signaling pathway according to the KEGG analysis. The gene discussed is TRIM26; the disease is osteosarcoma.